Scibase Ab Stock Fundamentals
Scibase AB fundamentals help investors to digest information that contributes to Scibase AB's financial success or failures. It also enables traders to predict the movement of Scibase Stock. The fundamental analysis module provides a way to measure Scibase AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Scibase AB stock.
Scibase |
Scibase AB Company Return On Equity Analysis
Scibase AB's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Scibase AB Return On Equity | -0.9 |
Most of Scibase AB's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Scibase AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Scibase AB has a Return On Equity of -0.8992. This is 96.25% lower than that of the Healthcare sector and 86.54% lower than that of the Diagnostics & Research industry. The return on equity for all Sweden stocks is 190.06% higher than that of the company.
Scibase AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Scibase AB's current stock value. Our valuation model uses many indicators to compare Scibase AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Scibase AB competition to find correlations between indicators driving Scibase AB's intrinsic value. More Info.Scibase AB is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Scibase AB's earnings, one of the primary drivers of an investment's value.Scibase Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Scibase AB's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Scibase AB could also be used in its relative valuation, which is a method of valuing Scibase AB by comparing valuation metrics of similar companies.Scibase AB is currently under evaluation in return on equity category among its peers.
Scibase Fundamentals
| Return On Equity | -0.9 | |||
| Return On Asset | -0.43 | |||
| Profit Margin | (2.41) % | |||
| Operating Margin | (2.59) % | |||
| Current Valuation | 208.42 M | |||
| Shares Outstanding | 68.48 M | |||
| Shares Owned By Insiders | 26.42 % | |||
| Shares Owned By Institutions | 16.44 % | |||
| Price To Earning | (2.75) X | |||
| Price To Book | 7.00 X | |||
| Price To Sales | 16.25 X | |||
| Revenue | 11.73 M | |||
| Gross Profit | 11.23 M | |||
| EBITDA | (38.82 M) | |||
| Net Income | (41.78 M) | |||
| Cash And Equivalents | 65.61 M | |||
| Cash Per Share | 3.49 X | |||
| Total Debt | 356 K | |||
| Current Ratio | 5.72 X | |||
| Book Value Per Share | 0.37 X | |||
| Cash Flow From Operations | (39.5 M) | |||
| Earnings Per Share | (0.66) X | |||
| Target Price | 11.0 | |||
| Number Of Employees | 21 | |||
| Beta | 1.51 | |||
| Market Capitalization | 195.86 M | |||
| Total Asset | 85.46 M | |||
| Retained Earnings | (352 M) | |||
| Working Capital | 96 M | |||
| Current Asset | 106 M | |||
| Current Liabilities | 10 M | |||
| Net Asset | 85.46 M |
About Scibase AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Scibase AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scibase AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scibase AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.SciBase Holding AB , a medical technology company, develops and sells skin cancer diagnostic instruments in Europe and internationally. The company was founded in 1998 and is headquartered in Stockholm, Sweden. Scibase Holding operates under Diagnostics Research classification in Sweden and is traded on Stockholm Stock Exchange. It employs 19 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Scibase Stock Analysis
When running Scibase AB's price analysis, check to measure Scibase AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scibase AB is operating at the current time. Most of Scibase AB's value examination focuses on studying past and present price action to predict the probability of Scibase AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scibase AB's price. Additionally, you may evaluate how the addition of Scibase AB to your portfolios can decrease your overall portfolio volatility.